U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07297745) titled 'Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism' on Dec. 09.
Brief Summary: The goal of this project is to improve the diagnostic pathway for patients with primary aldosteronism, by validating non-invasive biomarkers coupled with routine computed tomography imaging. The aim is to reduce reliance on invasive procedures, shorten diagnostic timelines, and enhance accessibility to definitive diagnosis and treatment globally.
Study Start Date: Jan. 02, 2026
Study Type: INTERVENTIONAL
Condition:
Hyperaldosteronism; Primary
Primary Aldosteronism Due to Aldosterone Producing Adenoma
Interventi...